JNS101

N/A

Report date: 2024/12/13 14:54:14
NME

Base Information

Drug NameJNS101
Drug Alias NameJNS101JNS-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJupiter Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesJupiter Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A